BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.13+0.00 (0.00%)
Close on Nov 18, 2026Market cap $3.26BP/E –Yield –
BGM revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $37.92M, up 51.1% from the year before. The highest annual figure on record is $64.86M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $37.92M | +51.1% |
| FY2024 | Sep 30, 2024 | $25.10M | -46.0% |
| FY2023 | Sep 30, 2023 | $46.47M | -28.3% |
| FY2022 | Sep 30, 2022 | $64.86M | +13.6% |
| FY2021 | Sep 30, 2021 | $57.10M | +14.1% |
| FY2020 | Sep 30, 2020 | $50.03M | +8.5% |
| FY2019 | Sep 30, 2019 | $46.10M | -8.5% |
| FY2018 | Sep 30, 2018 | $50.37M | – |
See a number that looks wrong?